J2KBIO Co., Ltd.
J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.
J2KBIO Co., Ltd. (420570) - Net Assets
Latest net assets as of September 2025: ₩33.04 Billion KRW
Based on the latest financial reports, J2KBIO Co., Ltd. (420570) has net assets worth ₩33.04 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩37.63 Billion) and total liabilities (₩4.59 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩33.04 Billion |
| % of Total Assets | 87.8% |
| Annual Growth Rate | 51.94% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 23.44 |
J2KBIO Co., Ltd. - Net Assets Trend (2021–2024)
This chart illustrates how J2KBIO Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for J2KBIO Co., Ltd. (2021–2024)
The table below shows the annual net assets of J2KBIO Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩31.34 Billion | +75.97% |
| 2023-12-31 | ₩17.81 Billion | +64.21% |
| 2022-12-31 | ₩10.85 Billion | +21.43% |
| 2021-12-31 | ₩8.93 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to J2KBIO Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 59.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩13.34 Billion | 42.57% |
| Common Stock | ₩2.87 Billion | 9.15% |
| Other Components | ₩15.13 Billion | 48.29% |
| Total Equity | ₩31.34 Billion | 100.00% |
J2KBIO Co., Ltd. Competitors by Market Cap
The table below lists competitors of J2KBIO Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SCI Engineered Materials Inc
OTCQB:SCIA
|
$11.76 Million |
|
Clientron Corp.
TWO:8119
|
$11.76 Million |
|
Nanoco Group plc
PINK:NNOCF
|
$11.76 Million |
|
DRONE DEL.CANAN.(VTG.SHS)
F:ABBA
|
$11.77 Million |
|
Emyria Ltd
AU:EMD
|
$11.75 Million |
|
Summit
TA:SMT
|
$11.75 Million |
|
Y-Optics Manufacture Co. Ltd
KQ:066430
|
$11.75 Million |
|
PIMS Inc.
KQ:347770
|
$11.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in J2KBIO Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 17,812,249,930 to 31,343,522,010, a change of 13,531,272,080 (76.0%).
- Net loss of 1,652,583,840 reduced equity.
- Share repurchases of 23,774,340 reduced equity.
- Other factors increased equity by 15,207,630,260.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-1.65 Billion | -5.27% |
| Share Repurchases | ₩23.77 Million | -0.08% |
| Other Changes | ₩15.21 Billion | +48.52% |
| Total Change | ₩- | 75.97% |
Book Value vs Market Value Analysis
This analysis compares J2KBIO Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.42x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.40x to 1.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | ₩1758.63 | ₩7740.00 | x |
| 2022-12-31 | ₩1952.33 | ₩7740.00 | x |
| 2023-12-31 | ₩3205.88 | ₩7740.00 | x |
| 2024-12-31 | ₩5467.39 | ₩7740.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently J2KBIO Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.27%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.99%
- • Asset Turnover: 0.92x
- • Equity Multiplier: 1.15x
- Recent ROE (-5.27%) is below the historical average (14.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 18.31% | 11.42% | 0.88x | 1.82x | ₩736.46 Million |
| 2022 | 19.23% | 13.01% | 0.91x | 1.62x | ₩1.00 Billion |
| 2023 | 27.19% | 17.01% | 1.29x | 1.24x | ₩3.06 Billion |
| 2024 | -5.27% | -4.99% | 0.92x | 1.15x | ₩-4.79 Billion |
Industry Comparison
This section compares J2KBIO Co., Ltd.'s net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $729,340,395,312
- Average return on equity (ROE) among peers: 5.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| J2KBIO Co., Ltd. (420570) | ₩33.04 Billion | 18.31% | 0.14x | $11.76 Million |
| DL Holdings CO. LTD. (000210) | $4.53 Trillion | 19.10% | 0.84x | $381.57 Million |
| Norooholdings (000320) | $402.45 Billion | 6.30% | 1.12x | $45.80 Million |
| Noroo Holdings Co Ltd (000325) | $583.54 Billion | 0.27% | 0.81x | $60.77 Million |
| Samhwa Paint (000390) | $299.72 Billion | 1.87% | 0.96x | $86.24 Million |
| Kangnam Jevisco Co Ltd (000860) | $366.15 Billion | 10.97% | 0.26x | $58.42 Million |
| Paik Kwang Ind (001340) | $204.57 Billion | 3.85% | 1.06x | $113.44 Million |
| Bo Lak (002760) | $43.76 Billion | 2.53% | 0.22x | $30.02 Million |
| Songwon Industrial (004430) | $543.25 Billion | 13.30% | 1.05x | $79.87 Million |
| Cho Kwang Pain (004910) | $172.73 Billion | -1.34% | 0.81x | $17.90 Million |
| Cosmoam&T (005070) | $147.00 Billion | -3.99% | 0.78x | $305.37 Million |